A new approach to the light/dark test procedure in mice

Pharmacology Biochemistry and Behavior

Volumn 60, Issue 3, 1998, Pages 645-653

  Hascoët, Martine ^a   Bourin, Michel ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

Anxiety; Anxiogenics; Anxiolytics; Light dark two compartment test; Mice; Procedure; Psychostimulants

Indexed keywords

ADRAFINIL; ALPRAZOLAM; AMINEPTINE; AMPHETAMINE; ANXIOLYTIC AGENT; CAFFEINE; DIAZEPAM; PSYCHOSTIMULANT AGENT;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; DRUG EFFECT; EXPLORATORY BEHAVIOR; LIGHT DARK CYCLE; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; STRAIN DIFFERENCE;

EID: 0031857585     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00031-8     Document Type: Article

References (41)

1. Armitage, P.; Berry, G.: Statistical methods in medical research, 2nd ed. Oxford: Blackwell; 203-205; 1987.
2. Barnes Costall, B.; Kelly, M. E.; Onaivi, E. S.; Naylor, R. J.: Ketotifen and its analogues reduce aversive responding in the rodent. Pharmacol. Biochem. Behav. 37:785-793; 1990.
3. Belzung, C.: Hippocampal mossy fibres: Implication in novelty reactions or in anxiety behaviors? Behav. Brain Res. 51:149-155; 1992.
4. Belzung, C.; Misslin, R.; Vogel, E.; Dodd, R. H.; Chapouthier, G.: Anxiogenic effects of methyl-β-carboline-carboxylate in a light/ dark choice situation. Pharmacol. Biochem. Behav. 28:29-33; 1987.
5. Blumstein, L. K.; Crawley, J. N.: Further characterisation of a simple, automated exploratory model for the anxiolytic effects of benzodiazepines. Pharmacol. Biochem. Behav. 18:37-40; 1983.
6. Boissier, J. R.; Simon, P.: Action de la caféine sur la motilité spontanée de la souris. Arch. Int. Pharmacodyn. 158:212-221; 1965.
7. Bourin, M.: Is it possible to predict the activity of a new antidepressant in animals with simple psychopharmacological test? Fundam. Clin. Pharmacol. 4:49-64; 1990.
8. Bourin, M.; Hascoët, M.; Mansouri, B.; Colombel, M. C.; Bradwejn, X.: Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models. J. Psychiatr. Neurosci. 17:72-77; 1992.
9. Bourin, M.; Redrobe, J. P.; Hascoët, M.; Baker, G. B.; Colombel, M. C.: A schematic representation of the psychopharmacological profile of antidepressants. Prog. Neuropsychopharmacol. Biol. Psychiatry 20:1389-1902; 1996.
10. Cappell, H.; Leblanc, A. E.: Punishment of saccharin drinking by amphetamine in rats and its reversal by chlordiazepoxide. J. Comp. Physiol. Psychol. 85:97-104; 1973.
11. Costall, B.; Domeney, A. M.; Kelly, M. E.; Tomkins, D. M.; Naylor, R. J.; Wong, E. H. F.; Smith, W. L.; Whiting, R. L.; Eglen, R.: The effect of the 5-HT3 receptor, RS 42358-197, in animal models of anxiety. 234:91-99; 1993.
12. Costall, B.; Jones, B. J.; Kelly, M. E.; Naylor, R. J.; Tomkins, X.: Exploration of mice in a black and white box: Validation as a model of anxiety. Pharmacol. Biochem. Behav. 32:777-785; 1989.
13. Costall, B.; Jones, B. J.; Kelly, M. E.; Naylor, R. J.; Onaivi, E. S.; Tyers, M. B.: Sites of action of ondansetron to inhibit withdrawal from drugs of abuse. Pharmacol. Biochem. Behav. 36:97-104; 1990.
14. Costall, B.; Jones, B. J.; Kelly, M. E.; Naylor, R. J.; Onaivi, E. S.; Tyers, M. B.: Ondansetron inhibits a behavioral consequence of withdrawing from drugs of abuse. Pharmacol. Biochem. Behav. 36:339-344; 1990.
15. Costall, B.; Kelly, M. E.; Naylor, R. J.; Onaivi, E. S.: Actions of buspirone in a putative model of anxiety in the mouse. J. Pharm. Pharmacol. 40:494-500; 1988.
16. Costall, B.; Naylor, R. J.: The pharmacology of the 5HT4 receptor. Int. Clin. Psychopharmacol. 8:11-18; 1993.
17. Crawley, J. N.: Neuropharmacologic specificity of a simple model for the behavioral actions of benzodiazepines. Pharmacol. Biochem. Behav. 15:695-699; 1981.
18. Crawley, J. N.; Belknap, J. K.; Collins, A.; Crabbe, J. C.; Frankel, W.; Henderson, N; Hitzemann, R. J.; Maxson, S. C.; Miner, L. L.; Silva, A. J.; Wehner, J. M.; Wynshaw-Boris, A.; Paylor, R.: Behavioral phenotypes of inbred mouse strains: implication and reommendations for molecular studies. Psychopharmacology (Berlin) 132:107-124; 1997.
19. Crawley, J. N.; Davis, L. G.: Base line exploratory activity predicts anxiolytics responsiveness to diazepam in five mouse strains. Brain. Res. Bull. 8:609-612; 1982.
20. Crawley, J. N.; Goodwin, F. K.: Preliminary report of a simple animal behavior for the anxiolytic effects of benzodiazepines. Pharmacol. Biochem. Behav. 13:167-170; 1980.
21. Crawley, J. N.; Skolnick, P.; Paul, S. M.: Absence of intrinsic antagonist actions of benzodiazepine antagonist on an exploratory model of anxiety in the mouse. Neuropharmacology 5:531-537; 1984.
22. Dawson, G. R.; Crawford, S. P.; Collinson, N.; Iversen, S. D.; Tricklebank, M. D.: Evidence that the anxiolytic-like effects of chlordiazepoxide in the elevated plus maze are confounded by increases in locomotor activity. Psychopharmacology (Berlin) 118:316-323; 1995.
23. De Angelis, L.: The anxiogenic-like effects of pentylenetetrazole in mice treated chronically with carbamazepine or valproate. Methods Find. Exp. Clin. Pharmacol. 14:767-771; 1992.
24. Duteil, J.; Rambert, F. A.; Pessonnier, J.; Gombert, R.; Assous, E.: A possible α adrenergic mechanism for drug (CRL 40028) induced hyperactivity. Eur. J. Pharmacol. 59:121-123; 1979.
25. File, S.: The use of social interactions as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J. Neurosci. Methods. 2:219-238; 1980.
26. Gao, B.; Cutler, M. G.: Effect of acute administration of the 5-HT3 receptor antagonist, BRL 46470A, on the behavior of mice in a two compartment light-dark box and during social interactions in their home cage and an unfamiliar neutral cage. Neuropharmacology 31:743-748; 1992.
27. Geller, I.; Seifter, J.: The effect of meprobamate, barbiturates, d-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacologia 1:482-492; 1960.
28. Griebel, G.: Variability in the effects of-5HT related compounds in experimental models of anxiety: Evidence for multiple mechanisms of 5-HT in anxiety or never ending story? Pol. J. Pharmacol. 48:129-136; 1996.
29. Hascoët, M.; Bourin, M.; Bradwejn, J.: Behavioral models in mice. Implication of the alpha noradrenergic system. Prog. Psychopharmacol. Biol. Psychiatry 15:825-840; 1991.
30. Hascoët, M.; Bourin, M.; Todd, K.; Couëtoux du Tertre, A.: Anticonflict effect of 5-HT1A agonists in rats: A new model of evaluating anxiolytic activity. J. Psychopharmacol. 8:227-237; 1994.
31. Imaizumi, M.; Miyazaki, S.; Onodera, K.: Effects of xanthine derivatives in a light/dark test in mice and contribution of adenosine receptors. Methods Find Exp. Clin. Pharmacol. 16:639-644; 1994.
32. Imaizumi, M.; Onodera, K.: The behavioral and biochemical effects of thioperamide, a histamine H3-receptor antagonist, in a light/dark test measuring anxiety in mice. Life Sei. 53:1675-1683; 1993.
33. Imaizumi, M.; Suzuki, T.; Machida, H.; Onodera, K.: A fully automated apparatus for a light/dark test measuring anxiolytic or anxiogenic effects of drugs in mice. Jpn. J. Psychopharmacol. 14:83-91; 1994.
34. Kilfoil, T.; Michel, A.; Montgomery, D.; Whiting, R. L.: Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in mice. Neuropharmacology 28:901-905; 1989.
35. Lister, R. G.: The use of a plus maze to measure anxiety in the mouse. Psychopharmacology (Berlin) 92:180-185; 1987.
36. Onaivi, E. S.; Martin, B. R.: Neuropharmacological and physiological validation of a computer-controlled two compartment black and white box for the assessment of anxiety. Prog. Neuropsychopharmacol. Biol. Psychiatry 13:963-976; 1989.
37. Pellows, S.; Chopin, P.; File, S. E.; Binley, M.: Validation of open:closed arm entries in an elevated plus maze as a measure of anxiety in the rat. J. Neurosci. Methods 14:149-167; 1985.
38. Shimada, T.; Matsumoto, K.; Osanai, M.; Matsuda, H.; Terasawa, K.; Watanabe, H.: The modified light/dark transition test in mice: Evaluation of classic and putative anxiolytic and anxiogenic drugs. Gen. Pharmacol. 26:205-210; 1995.
39. Treit, D.: Animals models for the study of anti-anxiety agents: A review. Neurosci. Biobehav. Rev. 9:203-222; 1985.
40. Volke, V.; Soosaar, A.; Koks, S.; Bourin, M.; Männistö, P. T.; Vasar, E.: 7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety. Psychopharmacology (Berlin) 131:399-405; 1997.
41. Young, R.; Johnson, D. N.: A fully automated light/dark apparatus useful for comparing anxiolytic agents. Pharmacol. Biochem. Behav. 40:739-743; 1991.